Sichuan Biokin Unit Receives $250 Million Milestone Payment from Bristol Myers Squibb
Sichuan Biokin Pharmaceutical says its unit received the second milestone payment under the Iza-Bren agreement.
Sichuan Biokin Pharmaceutical says its unit received the second milestone payment under the Iza-Bren agreement.